On Wednesday, Sept. 28, Sunil R. Hingorani, MD, PhD, professor at University of Washington School of Medicine and director of the Center for Accelerated Translation in Pancreas Cancer at Fred Hutchinson Cancer Research Center, will present “Targeting the Pancreas Cancer “Neo-Organ” to Therapeutic Advantage."
Hingorani, a medical oncologist and cancer biologist specializing in pancreas cancer, is also the founding director of the Pancreas Cancer Specialty Clinic at the Seattle Cancer Care Alliance (SCCA), a real-time multidisciplinary clinic which serves as the focal point for a comprehensive translational research program in pancreas cancer. His laboratory studies the molecular and cellular pathogenesis of pancreas cancer primarily through the use of genetically engineered mouse models. These animal models of distinct genetic subtypes of pancreas cancer form the basis for an integrated, systematic and multidisciplinary program of study.
Hingorani is currently PI of a national Phase 2 trial testing the strategy of enzymatic degradation of hyaluronan in combination with standard chemotherapy for metastatic pancreas cancer.
The Sept. 28 DCI Seminar Series will be held in room 143 of the Jones building. The Hematology Oncology Fellow presentation begins at 7:30 a.m. Hingorani will speak at 8:10 a.m.